Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 1801 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent

Read more ››

By: GlobeNewswire - 08 Apr 2024

XORTX Welcomes New Member to the Board of Directors

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: XORTX Therapeutics Inc

Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Venus Concept Inc.

IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: IntelGenx Technologies Corp.

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: BioRestorative Therapies, Inc.

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: TScan Therapeutics, Inc.

Syncromune® Inc. Presents Positive Results from SYNC-T™ SV-102 Phase 1 Trial at AACR Annual Meeting 2024

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Syncromune, Inc.

Metagenomi to Present at Upcoming Scientific Meetings

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Metagenomi, Inc.

EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”

Read more ››

By: GlobeNewswire - 08 Apr 2024

ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Oric Pharmaceuticals Inc.

Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Theriva Biologics, Inc.

Gritstone bio to Participate in Upcoming Investor and Scientific Conferences

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Gritstone bio

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: CytomX Therapeutics, Inc.

Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Corcept Therapeutics Incorporated

ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Oryzon Genomics, S.A. | Oryzon Genomics, S.A.

Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Biora Therapeutics, Inc.

INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: INmune Bio Inc.

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Mesa Labs, Inc.

Actuate Therapeutics Announces Poster Presentations at the 2024 AACR Annual Meeting

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Actuate Therapeutics, Inc.

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

Read more ››

By: GlobeNewswire - 08 Apr 2024

Related companies: Amarin Corporation plc

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑